Bank of America’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bank of America’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-121,300	Closed	-$11.4M	–	8703
2021 Q2	$11.4M	Buy	121,300 +19,300	+19%	+$1.78M	﹤0.01%	2698
2021 Q1	$9.39M	Buy	+102,000	New	+$8.61M	﹤0.01%	2790
2019 Q2	–	Sell	-359,700	Closed	-$9.51M	–	7632
2019 Q1	$9.51M	Buy	+359,700	New	+$8.52M	﹤0.01%	2530
2018 Q1	–	Sell	-11,800	Closed	-$172K	–	7484
2017 Q4	$172K	Buy	+11,800	New	+$166K	﹤0.01%	5483
2017 Q3	–	Sell	-250,000	Closed	-$2.97M	–	7419
2017 Q2	$2.97M	Sell	250,000 -260,000	-51%	-$3.23M	﹤0.01%	3524
2017 Q1	$7.54M	Buy	+510,000	New	+$8.26M	﹤0.01%	2670
2016 Q2	–	Sell	-40,300	Closed	-$668K	–	7554
2016 Q1	$668K	Buy	+40,300	New	+$705K	﹤0.01%	4409

Other funds holding HZNP

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

VWA

Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return

FSWA

Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return

BCMLT

Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Bank of America's HZNP Position: Q4 2023 in Review

Bank of America sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 1,025,402 shares — an estimated $119M sold.

Bank of America first reported a position in HZNP in Q2 2013 and held it in 42 quarters. The position peaked at $260M in Q1 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

Bank of America reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
Bank of America sold 1,025,402 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $119M.
Bank of America first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2013 and held it in 42 quarters.
Bank of America's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $260M in Q1 2023.
6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Bank of America's 13F filing for Q4 2023, filed 14 Feb 2024.